Pramodini Medicare
- Market cap
- ₹ 240 Cr.
- P/E
- 13.8x
- P/B
- 4.62x
- 52-week range
- 104 – 137
- ROE
- 39%
- ROCE
- 42%
- Debt / equity
- 0.34
- Sector
- Healthcare Services
- Industry
- Healthcare Service Provider
- Listed on
- NSE
About
Pramodini Medicare Ltd is a diagnostic service provider. The Company offers a range of technology-enabled diagnostic services such as radiology, clinical laboratory and nuclear medicine services to public hospitals, private hospitals, certain public sector undertakings (PSU) of the government of India and medical colleges. It also provides teleradiology service. It offers healthcare services for core testing, patient diagnosis, disease prevention and monitoring of various health conditions. Its services include both routine and specialized tests, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of diseases. Its diagnostic services include a comprehensive range of offerings, such as radiology, which covers magnetic resonance imaging (MRI), computed tomography (CT scan), and mammography and the clinical laboratory which includes hematology, micro-biology, immunology, pathology and biochemistry.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Healthcare Service Provider: 36 companies →Pramodini Medicare against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)13.8 against a typical 21: cheaper than most peers (1st = cheapest).8th of 34
- Size₹ 240.3 Cr. market value against a typical ₹ 83 Cr. (1st = largest).13th of 34
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 25 | 31 | 35 | 38 | 62 |
| Expenses | 13 | 16 | 20 | 17 | 31 |
| Operating Profit | 12 | 15 | 16 | 21 | 31 |
| OPM % | 49% | 49% | 44% | 55% | 50% |
| Other Income | 0 | 0 | 1 | 0 | 1 |
| Interest | 2 | 2 | 2 | 1 | 1 |
| Depreciation | 4 | 5 | 4 | 4 | 7 |
| Profit before tax | 7 | 8 | 10 | 16 | 23 |
| Tax % | 29% | 27% | 29% | 29% | 25% |
| Net Profit | 5 | 6 | 7 | 11 | 17 |
| EPS in Rs | 4.92 | 4.76 | 5.4 | 85.89 | 10.41 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 27%
- TTM
- 63%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 42%
- TTM
- 58%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 38%
- 3 Years
- 36%
- TTM
- —
P/E and EPS over time
Daily price to earnings ratio.
Peers
Listed companies in the same business.
| Pramodini Medicare | ₹ 109.00 | ₹ 240 Cr. | 13.8x | 4.6x | 39% | — |
| Apollo Hospitals Enterprise | ₹ 7,731.95 | ₹ 1,11,174 Cr. | 63.8x | 13.2x | — | 8.1% |
| Max Healthcare Institute | ₹ 817.00 | ₹ 79,519 Cr. | 67.2x | 9.3x | — | 16.7% |
| Fortis Healthcare | ₹ 720.00 | ₹ 54,357 Cr. | 62.1x | 6.6x | — | 11.3% |
| Aster DM Healthcare | ₹ 651.00 | ₹ 56,817 Cr. | 92.7x | 8.4x | — | 7.4% |
| Global Health | ₹ 1,165.00 | ₹ 31,449 Cr. | 67.9x | 9.5x | — | 11.8% |
Prices are delayed and for information only. Nothing on this page is investment advice.